Are Janus Kinase (JAK) Inhibitors Beneficial in the Treatment of Androgenic Alopecia?
October 2021
in “
International Journal of Dermatology
”
TLDR JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.
The study investigated the effects of Janus kinase inhibitors (JAKi) on androgenetic alopecia (AGA) in 18 men treated for various inflammatory skin conditions. Over an average treatment duration of 66 weeks, no improvement in AGA was observed, although hair loss did not worsen. This suggests that while JAKi may not stimulate hair regrowth in AGA, they could potentially protect against further hair loss. The study's limitations include a small sample size and lack of histologic analysis. Further long-term studies are needed to fully understand the role of JAKi in treating different types of alopecia.